EpilepsyGTx
Biotechnology company developing cutting-edge gene therapies to treat focal refractory epilepsy, a condition where seizures cannot be adequately controlled with current medications.
Investors
1
Categories
gene-therapy, epilepsy, neurology, therapeutics, biotech
Investors
| Name | Location | Type | Stages | Portfolio |
|---|---|---|---|---|
| AlbionVC (Healthcare) | London, UK | biotech-focused | seedseries-a+1 | 17 |